Personalized Cannabis Cannformatics specializes in saliva-based Cannabis-Responsive biomarkers to personalize medical cannabis treatment, signaling a potential sales angle with diagnostic partners, clinical researchers, and cannabis-focused healthcare providers seeking customized dosing solutions.

Small Team Advantage With a lean team of 2-10 employees, there is an opportunity to engage strategic partnerships or accelerator programs that can scale customer onboarding, professional services, and support without heavy enterprise overhead.

Scientific Validation Recent publications and advisory board appointments (including Montel Williams) highlight credibility in translational research and autism/dementia applications, suggesting opportunities to collaborate with academic institutions, pharma collaborators, and patient advocacy groups.

Healthcare Partnerships Active participation in medical cannabis symposiums and ongoing research indicates a pathway to connect with healthcare providers, clinics, and dispensaries seeking evidence-based tools to optimize patient-specific dosing.

Tech Stack Readiness Utilizing cloud, analytics, and web platforms (Google Cloud, Sentry, React, Wix) positions Cannformatics to adopt partner integrations, data pipelines, and front-end interfaces that can be co-developed or white-labeled for broader market adoption.